Archana Kumar, MD
Child & Adolescent Psychiatry · Greensboro, NCNPI 1326116286
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,402 of the $3,702 with a category attached, or 64.9%. 15 manufacturers reported payments, led by Johnson & Johnson at 39.1% of the total. Reporting peaked in 2019 at $1,477 and has fallen 94.9% since, to $75 in 2025. Among child & adolescent psychiatry clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 113 payments — averaging $32.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Neurocrine Biosciences, Inc.$705
- Alkermes, Inc.$297
- Lundbeck LLC$236
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$191
- Otsuka America Pharmaceutical, Inc.$179
- plus $646 from 9 others
What the payments were for
- Consulting fees$1,30035%
- Food & beverage$2,40265%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $1,448 |
| Neurocrine Biosciences, Inc. | 19 | $705 |
| Alkermes, Inc. | 15 | $297 |
| Lundbeck LLC | 11 | $236 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $191 |
| Otsuka America Pharmaceutical, Inc. | 9 | $179 |
| Teva Pharmaceuticals USA, Inc. | 13 | $172 |
| Vanda Pharmaceuticals Inc. | 8 | $145 |
| Indivior Inc. | 6 | $113 |
| E.r. Squibb & Sons, L.L.C. | 4 | $103 |
| Sunovion Pharmaceuticals Inc. | 2 | $40 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| USWM, LLC | 1 | $16 |
| Almatica Pharma LLC | 1 | $14 |
| Neuronetics, Inc. | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA TRINZA$1,300
- INVEGA SUSTENNA$1,300
- INGREZZA$377
How this compares
$3,702 in reported general payments places this provider in the 95th percentile of 91 child & adolescent psychiatry providers in North Carolina.
See all child & adolescent psychiatry providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other child & adolescent psychiatry in Greensboro
- Glenn JenningsGreensboro$896
- Onoriode EdehGreensboro$366
- Kim HooverGreensboro$246
- Steven SutherlandCharlotte$169K
- Shaheda MaroofRaleigh$8K
- Brian WallHillsborough$5K
- Bradley ReddickCharlotte$3K
- Jennifer HuHickory$3K
- Varsha VoraDurham$2K
- Mona IsmailWilmington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.